Relating to controlled substances, including amending the controlled substance schedules, removing certain references to marijuana, making penalties applicable, and including effective date provisions

This bill relates to controlled substances. The bill allows the board of pharmacy to change the scheduled status of cannabis-derived products and cannabis-derived investigational products based on scheduling decisions of the United States food and drug administration and the federal drug enforcement administration in the federal schedule of controlled substances. The bill classifies nine synthetic opioids, one opioid analgesic, ten synthetic cannabinoids, and seven synthetic cathinones as schedule I controlled substances under the Iowa uniform controlled substances Act (Act). The bill classifies all products which contain derivatives of barbituric acid (butalbital) as schedule III controlled substances under the Act, subject to reporting to the prescription monitoring program, and classifies one central nervous system depressant and one central nervous system stimulant as schedule IV controlled substances under the Act.1 percent tetrahydrocannabinols as a schedule V controlled substance under the Act. The bill strikes language referring to medical marijuana programs of the board of pharmacy. The bill is effective upon enactment.